Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIM for Recurrent C. difficile Diarrhea
NCT02857582Phase 2Completed
- Start
- Oct 2014
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Clostridium difficile infection (CDI) (3 arms). Primary endpoint: Normalization of stool consistency at 90 days. Started Oct 2014; status: completed.
02
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02857582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857582.